Verdane leads Significant Investment in Women's Health App Clue

• Clue​‍​‌‍​‍‌ has scored its biggest investment to date from Verdane
• The money is going to be used for product innovation and worldwide expansion
• The aim behind this is to target the missing parts of women’s health and wellness ​‍​‌‍​‍‌care

Clue, a women-led period and cycle tracker health and wellness app with over 100 million downloads globally - revealed that it had received a significant strategic investment from Verdane, a European growth equity firm specializing in technology-driven businesses.

This investment, which is a major element of Verdane’s €2 billion growth fund, represents the single largest investment in Clue so far and is a significant milestone for the company. As a result of the funding, Verdane will become the largest investor in the women's health and wellness ​‍​‌‍​‍‌app.

The​‍​‌‍​‍‌ investment goes after a fantastic 2025 year that has reinforced the growth foundations of Clue and has given them a clearly visible path towards long-term and sustainable profitability.

In partnership with Verdane, Clue has set its sights on the acceleration of its next growth phase by deepening product innovation, user experience and feature development; growing its global footprint by entering new and scaling existing markets; leveraging healthcare partnerships to bring more personalised care to a greater number of people; investing in clinical and world-class research to drive product excellence and continue closing the women’s health gap; strengthening their market-leading privacy-first and security measures; and investing in technology that supports the delivery of more personalised ​‍​‌‍​‍‌care.

Rhiannon​‍​‌‍​‍‌ White, the CEO at Clue, believes that women are the largest consumers of health and wellness globally. In fact, they control the majority of household spending in all markets. However, the paradox is that they are still very underserved when it comes to their health relative to their economic power.